Immunocore Holdings plc Cash And Cash Equivalents At Carrying Value

Quick Answer

Immunocore Holdings plc reported Cash And Cash Equivalents At Carrying Value of $467.71 million for the year ending 2025.

  • Immunocore Holdings plc showed an increase of +2.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Immunocore Holdings plc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Immunocore Holdings plc's Cash And Cash Equivalents At Carrying Value has grown by 16.2%.
  • Historical annual values: Fiscal year 2025: $467.71 million | Fiscal year 2024: $455.73 million | Fiscal year 2023: $442.63 million | Fiscal year 2022: $402.47 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: